ID,Title (News Shots) ,Title 2 (Press Release),"Content 1
 (News Shot)","Content 2
(Newswire.pharmashots.com)
PressRelease",Image URL,Categories,Company Name,Product ,Tags (Inidication|Category|Tags),Status,Date,userid
16995,20 Diagnostics Companies Based On 2018 Revenue,,"<p></p>

<!-- wp:paragraph -->
</p>
<p>With the era of growing diseases, Diagnostics have played a vital role in diagnosing multiple diseases and disorders. The healthcare system is changing, with a greater focus on value, reducing errors and giving more cost-effective care and treatments. The Diagnostic ledger has not changed much in comparison to 2017. Roche Diagnostics holds to be at the first position with generated revenue of $13B in top 20 Diagnostic firms. Our team at <a href=""https://www.pharmashots.com/"">PharmaShots</a> has compiled a list of top 20 diagnostics companies based on their 2018 diagnostics revenue.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17017} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Exact.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $0.45B </strong> <strong>                                                      Total Employees: ~1,977 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1995                                                                      Stock Exchange: NASDAQ   </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$15B                                                                        Headquarters: Wisconsin, </strong><strong style=""font-family: Roboto, sans-serif;font-size: 16px;font-style: normal"">United States</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has an accurate, non-invasive, screening test called Cologuard, used for the detection of colorectal cancer and precancer. Additionally, in 2018, Exact and Pfizer collaborated to co-promote Cologuard, a novel FDA approved non-invasive stool DNA screening test for colorectal cancer.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17018} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Varex.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $0.60B</strong> <strong>                                                     Total Employees: ~2,000 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 2017                                                                     Stock Exchange: NASDAQ</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$1.1B                                                                     Headquarters: Utah, </strong><strong style=""font-family: Roboto, sans-serif;font-size: 16px;font-style: normal"">United States</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Varex Imaging is a designer and manufacturer of X-ray imaging components including X-ray tubes, digital detectors and other image processing solutions. In Feb 2018, the company launched a new Power Chain solution line supporting computed tomography (CT) systems improving total cost of ownership, shorten development times, simplify the supply chain, and provide a higher level of system integration and support from the early stages of gantry design through product release and production.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17020} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/DiaSorin.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $0.76B </strong> <strong>                                                     Total Employees: ~1,971 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1968                                                                     Stock Exchange: BIT   </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$6.5B                                                                     Headquarters: Saluggia, Italy </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>DiaSorin is an Italian in-vitro diagnostics firm and is involved in developing, producing and commercializing diagnostic tests for a wide range of clinical areas. The tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics which are used to identify biological components aimed at determining the presence of specific elements in patient?s blood sample. In 2018, the company also launched LIAISON QuantiFERON TB Gold PLUS test for the detection of Tuberculosis.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17021} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Grifols-1.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $0.78B </strong> <strong>                                                     Total Employees: ~21,243</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1940                                                                     Stock Exchange: NASDAQ </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$19B                                                                       Headquarters: Barcelona, Spain </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Grifols is a global healthcare company dedicated to improving the health and well-being of people around the globe and is divided in four divisions- Bioscience, Diagnostic, Hospital and Bio Supplies. The company focusses on developing therapies for rare, chronic and life-threatening conditions. In Oct 2018, the company received FDA?s approval for ID CORE XT Test for IVD use in the US for molecular red blood cell typing. </p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17022} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Konica.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $0.84B</strong> <strong>                                                       Total Employees: ~44,360 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 2003                                                                       Stock Exchange: TYO </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$5.04B                                                                     Headquarters: Tokyo, Japan </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Konica Minolta is the global developer, manufacturer of multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment for healthcare systems, measuring instruments for industrial and healthcare applications, inkjet print heads and textile printers for industrial use, and related consumables and solution services.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17023} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Hologic.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $1.12B</strong> <strong>                                                       Total Employees: ~5,500 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1986                                                                       Stock Exchange: NASDAQ </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$13B                                                                        Headquarters: Massachusetts, United                                                                                                                   States </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Hologic is a medical technology company primarily focused on women?s health, beauty products development and marketing medical devices for surgery and medical imaging. Hologic is acquiring SuperSonic Imagine, a French based company for its Ultrasound products, which will further strengthen its breast health portfolio with best-in-class technology used for diagnosing cancer in women with dense breasts. The US FDA also granted PMA approval for Aptima HBV Quant Assay for quantitation of hepatitis B viral load on the fully automated Panther system.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17024} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/BioRad.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $1.41B</strong> <strong>                                                      Total Employees: ~8,260 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1952                                                                      Stock Exchange: NYSE </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$9.29B                                                                    Headquarters: California, United States </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Bio-Rad is a leading healthcare industry involved in blood typing products, offering a wide variety of platforms, reagents, data management, and connectivity solutions. In 2018, the company launched two process chromatography media, CHT Ceramic Hydroxyapatite XT media and Nuvia HP-Q Anion Exchange resin for protein purification of biotherapeutics.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17025} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/BD.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $1.50B </strong> <strong>                                                      Total Employees: ~76,032</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1895                                                                      Stock Exchange: NYSE </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$69B                                                                       Headquarters: New Jersey, United States </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products for physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Diagnostic segment has generated global sales of $1.50B in 2018 with total increment of 11.5% to 2017. Additionally, in 2018 BD acquired TVA Medical, a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17026} -->
</p>
<p><a href=""http://www.pharmashots.com/wp-content/uploads/2019/07/ortho-band-2.png""><img src=""http://www.pharmashots.com/wp-content/uploads/2019/07/ortho-band-2-1024x166.png"" alt="""" width=""747"" height=""121"" /></a></p>
<p> </p>
<figure></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $1.80B</strong> <strong>                                                      Total Employees: ~4, 400 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1939                                                                      Stock Exchange: N/A</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: NA                                                                             Headquarters: New Jersey, United States </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Ortho Clinical Diagnostics develops in-vitro products and diagnostic equipment for blood testing. In 2014, The Carlyle Group acquired the company from J&amp;J for $4.15B. The company, now operates as an independent entity. In 2018, company received FDA?s approval for its VITROS HIV Combo Test, a fourth-generation test used for detecting HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag) for use on Ortho's VITROS 3600 Immunodiagnostic System.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17027} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Sysmex.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $2.70B </strong> <strong>                                                      Total Employees: ~11,252 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1968                                                                      Stock Exchange: TYO</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$14.5B                                                                    Headquarters: Hyogo, Japan </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Sysmex is a Japanese firm involved in development, manufacturing, sales and export/import of diagnostic instruments, reagents and related softwares. In Dec 2018 its OncoGuide NCC Oncopanel System received manufacturing and marketing approval in Japan. Additionally, in 2018 Sysmex launched Automated Blood Coagulation Analyzers CN-6000 and CN-3000. The company diagnostic department generated sales of $2.7B in 2018.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17028} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Biomerieux.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $2.74B</strong> <strong>                                                        Total Employees: ~11,200 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1963                                                                        Stock Exchange: Euronext Paris</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$9.8B                                                                        Headquarters: Marcy-l'Étoile, France  </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>BioMerieux develops and produces in-vitro diagnostic solutions like systems, reagents, software and services for private and hospital laboratories, mainly for the diagnosis of infectious diseases. BioMerieux provides diagnostic solutions (systems, reagents, software) which determine the source of diseases and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases and for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. </p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17029} -->
</p>
<figure><a href=""http://www.pharmashots.com/wp-content/uploads/2019/07/9-1.png""><img src=""http://www.pharmashots.com/wp-content/uploads/2019/07/9-1-1024x151.png"" alt="""" width=""747"" height=""110"" /></a></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $3.50B</strong> <strong>                                                         Total Employees: ~31,844 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1934                                                                         Stock Exchange: TYO  </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$26B                                                                          Headquarters: Tokyo, Japan </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Fujifilm Medical is a leader in diagnostic imaging products and medical informatics solutions and is divided into three business categories: Imaging Solutions, Healthcare &amp; Material Solutions and Document Solutions. In Apr, 2018 Fujifilm collaborated with LPixel to use AI technology designed to support diagnosing medical images.  </p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17042} -->
</p>
<figure><a href=""http://www.pharmashots.com/wp-content/uploads/2019/07/8.png""><img src=""http://www.pharmashots.com/wp-content/uploads/2019/07/8-1024x150.png"" alt="""" width=""747"" height=""109"" /></a></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $3.72B</strong>                                                         <strong>Total Employees: ~70,000 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1902                                                                        Stock Exchange: NYSE   </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$118B                                                                       Headquarters: Massachusetts,                                                                                                                               United States</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Thermo Fisher is serving globally with its primary brands: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. The Specialty Diagnostic of Thermo Fischer generated sales of $3.72B which grew 7% more than the 2017 revenue. Additionally, in 2018 Thermo Fischer launched its Complementary Diagnostic Immunoassay used for measuring the concentration of a novel therapeutic antibiotic, plazomicin, using the automated clinical chemistry analyzer, Beckman Coulter AU 680.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17031} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Canon-1.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $4.04B</strong> <strong>                                                     Total Employees: ~25,891 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1937                                                                     Stock Exchange: TYO   </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$39.61B                                                                  Headquarters: Tokyo, Japan </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Canon Inc. is a Japanese multinational corporation specialized in the manufacturing of imaging and optical products, including cameras, camcorders, photocopiers, steppers, computer printers and medical equipment?s. Canon Medical?s next-generation 3-Tesla MRI scanner, the Vantage Galan 3T, maximizes high-resolution imaging performance while minimizing space requirements and energy consumption. The device also employs noise-reduction technology to provide greater comfort to patients.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17032} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Siemens.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $4.49B</strong> <strong>                                                      Total Employees: ~50,000 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1971                                                                      Stock Exchange: ETR </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$35.59B                                                                  Headquarters: Erlangen, Germany</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Siemens Healthineers is a subsidiary of Siemens AG, a diagnostic company focused on the development of diagnostic, therapeutic imaging, laboratory diagnostics, molecular medicine, digital health services, and enterprise services. In Aug, 2018, Siemens Healthineers collaborated with NuVasive to develop and advance technology designed for minimally invasive spinal surgery.Its diagnostic segment generated sales of $4.49B in 2018.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17033} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/GE-healthcare.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $4.90B </strong> <strong>                                                         Total Employees: ~53,800 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1994                                                                        Stock Exchange: NYSE </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: NA                                                                               Headquarters: Illinois, United States </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>GE Healthcare is a leading global wholly owned subsidiary of General Electric Company focused on the development, manufacturing, and commercialization of healthcare technologies. The portfolio provides solutions and products in diagnosis, treatment, and monitoring of patients. The company has more than 4M imaging, mobile diagnostics and monitoring units installed globally in 43 global centers. GE Healthcare also have an AIR Technology, AI-based technology for intelligent MR slice presentation using artificial neural networks delivering consistent and accurate scans.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17034} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Danaher.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $6.35B </strong> <strong>                                                      Total Employees: ~71,000 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1969                                                                      Stock Exchange: NYSE </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$102B                                                                    Headquarter: Washington, D.C                                                                                                                                </strong><strong style=""font-size: 16px"">United States</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The company has focus on Life Sciences, Diagnostics, Dental, and Environmental &amp; Applied Solutions. The Danaher?s Diagnostic segment generated sales of $6.3B in 2018. Additionally, Danaher acquired Integrated DNA Technologies (IDT) to expand its footprint in genomic market and to develop diagnostic tests and lifesaving therapies.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17035} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Abbott.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $7.49B                                                           Total Employees: ~103,000</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1900                                                                          Stock Exchange: NYSE</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$149B                                                                         Headquarter: Illinois, United States                                                                </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Abbott Laboratories is an American healthcare company with a broad pipeline of generics, diagnostic, natural products, cardiovascular and neuromodulation products. Its Diagnostic segment is divided in four divisions Rapid Diagnostics, Molecular Diagnostics, Core Laboratory Diagnostics, Diabetes Care. Abbott has also introduced a Diagnostic system Alinity, in EU and other markets which is usually involved in clinical chemistry, immunoassays, molecular diagnostics, hematology, POC testing, and blood and plasma screening.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17037} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Philips.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $8.10B                                                         Total Employees: ~77,400 </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1891                                                                        Stock Exchange: NYSE </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$39.92B                                                                   Headquarter: Amsterdam, The                                                                                                                                Netherlands </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Philips Healthcare has focused their research and development efforts to develop new approaches in the areas of radiology, cardiology, oncology, decision support, home health, respiratory and other critical areas. Its parent company, Royal Philips is a diversified company focusing on improving public health with meaningful innovation offering treatments at a lower cost. Philips Healthcare@home providing a wide range of healthcare services at the patient?s home with the help of experienced and certified in Basic Life Support (BLS) professionals.</p>
<p>
<!-- /wp:paragraph -->

<!-- wp:image {""id"":17038} -->
</p>
<figure><img src=""https://www.pharmashots.com/wp-content/uploads/2019/07/Roche.png"" alt="""" /></figure>
<p>
<!-- /wp:image -->

<!-- wp:paragraph -->
</p>
<p><strong>Diagnostic Revenue: $13.08B                                              Total Employees: ~92,400</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Founded Year: 1896                                                               Stock Exchange: SWX</strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p><strong>Market Cap: ~$230B                                                              Headquarter: Basel, Switzerland </strong></p>
<p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
</p>
<p>Roche is a Swiss multinational healthcare company operating worldwide under pharmaceuticals and diagnostics divisions. Roche has a focus on multiple therapy areas including ophthalmology, oncology and immunology. The Diagnostics segment of Roche is divided into four segments: Molecular Diagnostics, Diabetes Care, Tissue Diagnostics, Centralized and Point of Care Solutions. The total revenue generated by Diagnostic segment is $13.08B</p>
<p>
<!-- /wp:paragraph -->

<p></p>",,https://pharmashots.com/wp-content/uploads/2019/07/Top20-biopharm-Companies3.png,Top 20,Top 20 Diagnostics Companies,,Abbott|Based|Becton Dickinson|Bio-Rad|BioMerieux|Canon|Companies|Danaher|Diagnostics|DiaSorin|Fujifilm|GE Healthcare|Grifols|Hologic|Konica Minolta|Ortho Clinical Diagnostics|Philips|Revenue|Roche|Siemens Healthineers|Sysmex|Thermo Fischer|Top 20|Varex Imaging,publish,2021-11-19,2
